Demonstration of the Burkitt's lymphoma Epstein-Barr virus phenotype in dividing latently infected memory cells in vivo

Epstein-Barr virus (EBV) is a herpesvirus that establishes a lifelong, persistent infection. It was first discovered in the tumor Burkitt's lymphoma (BL). Despite intensive study, the role of EBV in BL remains enigmatic. One striking feature of the tumor is the unique pattern of viral latent protein expression, which is restricted to EBV-encoded nuclear antigen (EBNA) 1. EBNA1 is required to maintain the viral genome but is not recognized by cytotoxic T cells. Consequently, it was proposed that this expression pattern was used by latently infected B cells in vivo. This would be the site of long-term, persistent infection by the virus and, by implication, the progenitor of BL. We now know that EBV persists in memory B cells in the peripheral blood and that BL is a tumor of memory cells. However, a normal B cell expressing EBNA1 alone has been elusive. Here we show that most infected cells in the blood express no detectable latent mRNA or proteins. The exception is that when infected cells divide they express EBNA1 only. This is the first detection of the BL viral phenotype in a normal, infected B cell in vivo. It suggests that BL may be a tumor of a latently infected memory B cell that is stuck proliferating because it is a tumor and, therefore, constitutively expressing only EBNA1.

[1]  J. Yates,et al.  Stable replication of plasmids derived from Epstein–Barr virus in various mammalian cells , 1985, Nature.

[2]  K. Rajewsky,et al.  Maintenance of B-cell memory by long-lived cells generated from proliferating precursors , 1990, Nature.

[3]  J. Pagano,et al.  Expression of EBNA-1 mRNA Is Regulated by Cell Cycle during Epstein-Barr Virus Type I Latency , 1999, Journal of Virology.

[4]  D. Thorley-Lawson,et al.  Epstein-Barr virus and the B cell: that's all it takes. , 1996, Trends in microbiology.

[5]  J. Robinson,et al.  Plasmacytic differentiation of circulating Epstein-Barr virus-infected B lymphocytes during acute infectious mononucleosis , 1981, The Journal of experimental medicine.

[6]  G. Winberg,et al.  A subpopulation of normal B cells latently infected with Epstein-Barr virus resembles Burkitt lymphoma cells in expressing EBNA-1 but not EBNA-2 or LMP1 , 1995, Journal of virology.

[7]  D. Thorley-Lawson,et al.  Tonsillar memory B cells, latently infected with Epstein-Barr virus, express the restricted pattern of latent genes previously found only in Epstein-Barr virus-associated tumors. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[8]  D. Rowe,et al.  Epstein-Barr virus latent gene expression in uncultured peripheral blood lymphocytes , 1992, Journal of virology.

[9]  D. Thorley-Lawson,et al.  The expression pattern of Epstein-Barr virus latent genes in vivo is dependent upon the differentiation stage of the infected B cell. , 2000, Immunity.

[10]  K. Rajewsky,et al.  Burkitt’s Lymphoma Is a Malignancy of Mature B Cells Expressing Somatically Mutated V Region Genes , 1995, Molecular medicine.

[11]  M. Lipinski,et al.  Identification of a subset of normal B cells with a Burkitt's lymphoma (BL)-like phenotype. , 1987, Journal of immunology.

[12]  M. Rowe,et al.  Different Epstein-Barr virus-B cell interactions in phenotypically distinct clones of a Burkitt's lymphoma cell line. , 1990, The Journal of general virology.

[13]  Bin Yang,et al.  Identification of the Site of Epstein-Barr Virus Persistence In Vivo as a Resting B Cell , 1998, Journal of Virology.

[14]  J. Strominger,et al.  Redefining the Epstein-Barr virus-encoded nuclear antigen EBNA-1 gene promoter and transcription initiation site in group I Burkitt lymphoma cell lines. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[15]  M. Epstein,et al.  Epstein-Barr (EB) virus genome-containing, EB nuclear antigen-negative B-lymphocyte populations in blood in acute infectious mononucleosis. , 1978, The Journal of general virology.

[16]  D. Thorley-Lawson,et al.  A model for persistent infection with Epstein-Barr virus: the stealth virus of human B cells. , 1999, Life sciences.

[17]  K. Rajewsky,et al.  Lack of deleterious somatic mutations in the CD95 gene of plasmablasts from systemic lupus erythematosus patients and autoantibody‐producing cell lines , 2002, European journal of immunology.

[18]  J. Niederman,et al.  Mitotic EBNA-positive lymphocytes in peripheral blood during infectious mononucleosis , 1980, Nature.

[19]  J. Strominger,et al.  A simple reverse transcriptase PCR assay to distinguish EBNA1 gene transcripts associated with type I and II latency from those arising during induction of the viral lytic cycle , 1996, Journal of virology.

[20]  G. Klein Epstein-Barr virus strategy in normal and neoplastic B cells , 1994, Cell.

[21]  L. Young,et al.  Epstein-Barr virus latency in blood mononuclear cells: analysis of viral gene transcription during primary infection and in the carrier state , 1994, Journal of virology.

[22]  D. Thorley-Lawson,et al.  EBV persistence in memory B cells in vivo. , 1998, Immunity.

[23]  J. Arrand,et al.  Characterization of the major Epstein-Barr virus-specific RNA in Burkitt lymphoma-derived cells , 1982, Journal of virology.

[24]  D. Thorley-Lawson,et al.  EBV Persistence Involves Strict Selection of Latently Infected B Cells1 , 2000, The Journal of Immunology.

[25]  D. Thorley-Lawson,et al.  Epstein-Barr virus: exploiting the immune system , 2001, Nature Reviews Immunology.

[26]  D. Thorley-Lawson,et al.  A novel form of Epstein-Barr virus latency in normal B cells in vivo , 1995, Cell.

[27]  I. Ernberg,et al.  Epstein-Barr virus: adaptation to a life within the immune system. , 1994, Trends in microbiology.

[28]  R. Freeman,et al.  The dispersal of mucosal memory B cells: evidence from persistent EBV infection. , 2002, Immunity.

[29]  R. Freeman,et al.  Epstein-Barr Virus–Infected Resting Memory B Cells, Not Proliferating Lymphoblasts, Accumulate in the Peripheral Blood of Immunosuppressed Patients , 1999, The Journal of experimental medicine.

[30]  M. Epstein,et al.  The Epstein-Barr Virus , 1979, Springer Berlin Heidelberg.

[31]  T. Kurosaki,et al.  Genetic analysis of B cell antigen receptor signaling. , 1999, Annual review of immunology.